?????????????????????????????????????? Unfit people even have the alternative of venetoclax furthermore obinutuzumab (VO) as frontline therapy. This is based with a period III trial that as opposed VO with ClbO in aged/unfit sufferers.113 VO was excellent with regards to reaction amount and progr